Clearpoint Neuro, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
ClearPoint Neuro, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 20, 2026, to elect directors, ratify auditors, and approve executive compensation and an incentive plan.
NASDAQ
ClearPoint Neuro's proxy statement details the agenda for the annual stockholder meeting on May 21, 2025, including director elections and compensation plan approvals.
NASDAQ
DEF 14A: ClearPoint Neuro Seeks Stockholder Approval for Amended Incentive Plan and Director Elections
ClearPoint Neuro is holding its annual meeting on May 15, 2024, to vote on director elections, executive compensation, auditor ratification, and an amended incentive compensation plan.